Elliptic Laboratories AS (ELABS) — Financial Flexibility Index
Elliptic Laboratories AS (ELABS) has a Financial Flexibility Index of -0.36x as of March 2026. Free cash flow of Nkr-11.96 Million (operating CF Nkr-17.60 Million minus capex Nkr5.63 Million) represents 0% of total liabilities (Nkr33.36 Million). Check total reinvestment intensity of Elliptic Laboratories AS to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elliptic Laboratories AS Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Elliptic Laboratories AS across 9 annual periods. For the full cash flow conversion analysis, see Elliptic Laboratories AS operating cash flow efficiency.
Annual Financial Flexibility Index for Elliptic Laboratories AS (2017–2025)
Year-by-year free cash flow to debt coverage for Elliptic Laboratories AS. Explore ELABS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.10x | Nkr35.08 Million | Nkr5.99 Million | Nkr31.87 Million | ▲ +97.4% |
| 2024 | 0.56x | Nkr19.89 Million | Nkr-10.61 Million | Nkr35.69 Million | ▲ +219.9% |
| 2023 | -0.46x | Nkr-19.90 Million | Nkr-45.51 Million | Nkr42.80 Million | ▼ -204.3% |
| 2022 | 0.45x | Nkr10.57 Million | Nkr-12.76 Million | Nkr23.70 Million | ▲ +87.8% |
| 2021 | 0.24x | Nkr6.79 Million | Nkr-10.82 Million | Nkr28.59 Million | ▼ -13.7% |
| 2020 | 0.28x | Nkr8.42 Million | Nkr-6.68 Million | Nkr30.62 Million | ▲ +435.4% |
| 2019 | 0.05x | Nkr3.05 Million | Nkr-8.05 Million | Nkr59.34 Million | ▲ +110.7% |
| 2018 | -0.48x | Nkr-26.42 Million | Nkr-35.16 Million | Nkr54.84 Million | ▲ +65.8% |
| 2017 | -1.41x | Nkr-37.50 Million | Nkr-38.87 Million | Nkr26.59 Million | — |